EIF2AK3 and cancer: To further test this, we utilized the Cancer Therapeutics Response Portal (CTRP) database[23] to analyze the correlation of sensitivity to WEE1 inhibitors with PERK and XBP1s activity, represented by the above described gene signatures of PERK and XBP1s (Table S1, Supporting Information).